MyFinsight
Home
Blog
About
BIOVIE INC. (BIVI)
BIOVIE INC. (BIVI)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from issuance of co...
Stock based compensation expense...
Accounts payable and accrued exp...
Others
Negative Cash Flow Breakdown
Net loss
Prepaid and other current assets
Operating lease liability
Grant receivable
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2026-06-30
2025-06-30
Stock based compensation - restricted stock units and restricted shares
-
1,202,809
Stock based compensation expense - issuance of common stock for services rendered
0
73,680
Amortization of financing costs
0
11,820
Accretion of unearned loan discount
0
-111,212
Gain on termination of operating lease
-
0
Accretion of loan premium
0
25,758
Change in fair value of derivative liabilities
0
3,771
Net loss
-22,072,863
-17,542,120
Stock based compensation - restricted stock units and restricted shares
-589,710
-
Realized gain on maturity of available-for sale
-
0
Stock based compensation expense - stock options
2,283,809
1,195,447
Non-cash lease expense from right-of-use asset
77,067
67,073
Grant receivable
-47,390
2,104,050
Prepaid and other current assets
1,463,458
845,505
Other current liabilities
-
0
Accounts payable and accrued expenses
1,504,442
-1,386,592
Operating lease liability
-74,464
-60,343
Amortization of intangible assets
178,341
229,377
Net cash used in operating activities
-19,024,806
-19,025,205
Proceeds from u.s. treasury bills (available-for-sale)
-
0
Proceeds from exercise of warrants
0
-
Net cash provided by investing activities
-
0
Payment of loan premium
0
-
Payment of note payable
0
5,000,000
Net proceeds from issuance of common stock
10,457,629
15,674,613
Payment of loan premium
-
850,000
Proceeds from exercise of warrants
-
2,901,341
Net cash provided by financing activities
10,457,629
12,725,954
Net change in cash and cash equivalents
-8,567,177
-6,299,251
Cash and cash equivalents, beginning of period
17,544,547
-
Cash and cash equivalents, end of period
8,977,370
-
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
issuance of common stock
$10,457,629
(-33.28%↓ Y/Y)
Net cash provided by
financing activities
$10,457,629
(-17.82%↓ Y/Y)
Net change in cash
and cash...
-$8,567,177
(-36.00%↓ Y/Y)
Canceled cashflow
$10,457,629
Stock based
compensation expense - stock...
$2,283,809
(91.04%↑ Y/Y)
Accounts payable and
accrued expenses
$1,504,442
(208.50%↑ Y/Y)
Stock based
compensation - restricted...
-$589,710
(-149.03%↓ Y/Y)
Amortization of intangible
assets
$178,341
(-22.25%↓ Y/Y)
Non-cash lease expense
from right-of-use...
$77,067
(14.90%↑ Y/Y)
Net cash used in
operating activities
-$19,024,806
(0.00%↑ Y/Y)
Canceled cashflow
$4,633,369
Net loss
-$22,072,863
(-25.83%↓ Y/Y)
Prepaid and other
current assets
$1,463,458
(73.09%↑ Y/Y)
Operating lease liability
-$74,464
(-23.40%↓ Y/Y)
Grant receivable
-$47,390
(-102.25%↓ Y/Y)
Buy us a coffee